Analysis Note
Negative ControlHepG2 cells or normal skin
Positive ControlSK-BR-3 cells or breast carcinoma tissue
Application
Frozen Sections (2.5 g/ml)Immunoblotting (2-3 g/ml, see application references)Immunofluorescence (2.5 g/ml)Immunoprecipitation (1 g/sample, see application references)Paraffin Sections (2.5 g/ml, pressure cooker, heat or trypsin pre-treatment required, see application references)
General description
Recognizes the ~185 kDa c-ErbB2/c-Neu protein in HEK293 cells.
Anti-c-ErbB2/c-Neu (Ab-3), mouse monoclonal, clone 3B5, recognizes the ~185 kDa c-ErbB2/c-Neu protein in HEK293 cells. It is validated for WB, IF, IP, and IHC on frozen and paraffin sections.
Purified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with Sp2/0.Ag14 cells (see application references). Recognizes the ~185 kDa c-Erb2/c-Neu protein.
Immunogen
a synthetic peptide (TAENPEYLGLDVPV) corresponding to amino acids 1242-1255 from the C-terminal domain of human c-ErbB2/c-Neu
Human
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
For paraffin sections, we recommend pre-treating with a pressure cooker, but trypsin and heat will also work well. Including 0.05% saponin during staining of paraffin sections may help reduce background. In one study ductal carcinomas in situ displaying large-cell, comedo growth type, were stained while none of 16 ductal carcinomas in situ of small-cell, papillary, or cribriform growth type were stained by this antibody. Antibody should be titrated for optimal results in individual systems.
Mamcs, J.R., et al. 1994. Ann. Surg.219, 332.Tetu, B., et al. 1994. Cancer73, 2359.DiFiore, P.P., et al. 1987. Science237, 178.Slamon, D.J., et al. 1987. Science235, 177.Varley, J.M., et al. 1987. Oncogene1, 423.Bargmann, C.I., et al. 1986. Nature319, 226.Yamamoto, T., et al. 1986. Nature319, 230.Blick, M., et al. 1984. Blood64, 1234.Schwab, M., et al. 1984. Cold Spring Harbor Laboratory 2, 215.
Packaging
100 µg in Plastic ampoule
Please refer to vial label for lot-specific concentration.
Physical form
In 0.05 M sodium phosphate buffer, 0.2% gelatin.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: